SCL

Business Context and Reporting Period

Company: Stepan Company
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended September 30, 2005
Business Overview: Stepan Company manufactures and markets specialty chemicals, primarily surfactants, polymers, and specialty products. The company operates globally with significant segments in the United States, Europe, Mexico, and Brazil.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 11% in Q3 and 16% for the nine-month period. Growth was driven by higher selling prices (pass-through of raw material costs), increased sales volume (particularly in biodiesel and foreign operations), and favorable foreign currency translation.
• Profitability: Operating income doubled in Q3 (up 100%) and rose 33% for the nine-month period. Net income increased 120% in Q3 and 40% year-to-date.
• Segment Performance:
  • Surfactants: Sales and operating income increased significantly, driven by biodiesel volume and a $1.6 million insurance gain from a 2004 UK fire.
  • Polymers: Sales volume declined (especially in polyurethane polyols due to roofing insulation market weakness), but operating income improved due to price increases.
  • Specialty Products: Sales and income rose in Q3 due to pharmaceutical and flavoring volume, though year-to-date sales were slightly down.
• Expenses: Operating expenses increased due to higher deferred compensation, salary, pension, and profit-sharing costs. Administrative expenses were partially offset by lower legal and system implementation costs.
• Debt: Total debt increased by $15.4 million year-to-date to fund working capital requirements.

Guidance, Outlook, and Risks

• Outlook: Management expects surfactant earnings to improve in Q4. However, polymer volumes sold to the roof insulation market are expected to remain weak into Q1 2006 due to high material costs delaying repairs.
• Cost Pressures: Rising crude oil and natural gas prices continue to increase raw material, freight, and utility costs. The company plans to continue raising prices to recover these costs.
• Biodiesel: High crude oil prices are favorable for biodiesel economics; the plant is running at 100% capacity with expansion projects underway.
• Capital Expenditures: Expected to range between $40.0 million and $47.0 million for 2005.
• Environmental & Legal: The company faces potential liabilities at 21 waste disposal sites. The estimated range of possible losses is $8.3 million to $40.2 million, with an accrued liability of $18.5 million. Management believes these matters will not have a material effect on financial position.
• Debt Agreement: On September 29, 2005, the company entered an agreement to issue $40 million in senior notes (5.69% fixed rate) to be received in November 2005 to pay down bank debt.
• Tax Repatriation: The company elected to repatriate foreign earnings in Q4 2005, which will add approximately $485,000 to Q4 income tax expense.

Investor Verification Checklist

• Insurance Proceeds: Verify the impact of the $1.6 million insurance gain (Q3) and $0.9 million business interruption proceeds (Q1) on gross profit margins.
• Raw Material Costs: Assess the company's ability to pass through rising crude oil and natural gas costs to customers without losing significant volume.
• Debt Covenants: Review the new $40 million note agreement and existing credit facilities for compliance with financial ratios.
• Environmental Reserves: Monitor the $18.5 million accrued liability against the $8.3M–$40.2M estimated loss range for potential future adjustments.
• Segment Mix: Evaluate the sustainability of biodiesel volume growth versus the structural weakness in the polyurethane polyols market.